Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | DAO | P14920 | 1/20 | 0.50 |
| ▸ | CSNK2A1 | P68400 | 4/20 | 0.45 |
| ▸ | CSNK2A2 | P19784 | 3/20 | 0.45 |
| ▸ | CSNK2B | P67870 | 3/20 | 0.45 |
| ▸ | CSNK2A3 | Q8NEV1 | 3/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.42 |
| ▸ | PIM1 | P11309 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | APEX1 | P27695 | 1/20 | 0.41 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.39 |
| ▸ | MME | P08473 | 1/20 | 0.38 |
| ▸ | MMEL1 | Q495T6 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL3328070 | 0.97 | KDM4E (0.50) | KDM4EKMT2ADAOCSNK2A1CSNK2A2 | |
| SCHEMBL11646687 | 0.97 | KDM4E (0.50) | KDM4EKMT2ADAOCSNK2A1CSNK2A2 | |
| SCHEMBL742929 | 0.89 | KDM4E (0.44) | KDM4EKMT2ADAOCSNK2A1CSNK2A2 | |
| Water SCHEMBL3111204 | 0.87 | KDM4E (0.42) | KDM4EKMT2ADAOCSNK2A1CSNK2A2 | |
| SCHEMBL1176813 | 0.84 | NQO1 (0.58) | KDM4EKMT2ADAOCSNK2A1CSNK2A2 | |
| SCHEMBL27546475 | 0.84 | KDM4E (0.44) | KDM4EKMT2ADAOCSNK2A1CSNK2A2 | |
| SCHEMBL12867868 | 0.79 | KMT2A (0.50) | KDM4EKMT2ADAOCSNK2A1CSNK2A2 | |
| Chelidamic Acid SCHEMBL1535360 | 0.78 | ALOX15 (0.60) | KDM4EKMT2ADAOCSNK2A1CSNK2A2 | |
| SCHEMBL1176530 | 0.77 | ALDH1A1 (0.58) | KDM4EKMT2ACSNK2A1CSNK2A2CSNK2B | |
| SCHEMBL13460269 | 0.76 | LMNA (0.62) | KDM4EKMT2ASMN1; SMN2ALDH1A1APEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 981 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122031454-A | Application of chelidonic acid in preparing medicament for treating fungal keratitis | 青岛大学附属医院 | 2026-05-15 | — | — | CN | claimed |
| US-20260042084-A1 | SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP | GENERAL ELECTRIC TECHNOLOGY GMBH (CH) | 2026-02-12 | — | — | US | claimed |
| EP-4680369-A1 | SYSTEMS FOR CARBON DIOXIDE CAPTURE USING FUNCTIONALIZED SORBENTS AND WATER MANAGEMENT | GE Vernova Technology GmbH (CH) | 2026-01-21 | — | — | EP | claimed |
| US-12485112-B2 | Pharmaceutical composition | ASCLEPIUS PHARMACEUTICAL LLC (US) | 2025-12-02 | — | — | US | claimed |
| WO-2025238576-A1 | SYSTEM AND METHOD FOR STORING LIQUIDS HAVING LOW LATENT HEAT OF VAPORIZATION | Nuovo Pignone Tecnologie – S.r.l. (IT) | 2025-11-20 | — | — | WO | claimed |
| US-20250354659-A1 | SYSTEM AND METHOD FOR STORING LIQUIDS HAVING LOW LATENT HEAT OF VAPORIZATION | NUOVO PIGNONE TECNOLOGIE – S R L (IT) | 2025-11-20 | — | — | US | claimed |
| EP-4615506-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | Sahin, Fikret (TR) | 2025-09-17 | — | — | EP | claimed |
| EP-4572884-A1 | SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP | General Electric Technology GmbH (CH) | 2025-06-25 | — | — | EP | claimed |
| EP-4556112-A2 | SORBENT COMPOSITIONS, SYSTEMS, AND METHODS | General Electric Technology GmbH (CH) | 2025-05-21 | — | — | EP | claimed |
| CN-119351022-B | Epoxy resin cement and preparation method thereof | 洛阳龙羽电气设备有限公司 | 2025-05-13 | — | — | CN | claimed |
| WO-2003079976-A2 | A SUBSTANCE WITH SEDATIVE EFFECT | TECHNOLOGY COMMERCIALIZATION CORP. (US) | 2003-10-02 | — | — | WO | claimed |
| US-20030181516-A1 | Substance with sedative effect | TECHNOLOGY COMMERCIALIZATION CORP. | 2003-09-25 | — | — | US | claimed |
| US-6605142-B1 | Copper, nickel, or manganese carboxylate and colorant; ink jet printing | AVECIA LIMITED (GB) | 2003-08-12 | — | — | US | claimed |
| CN-1373795-A | Chemical composition for ink | AVECIA LTD (GB) | 2002-10-09 | — | — | CN | claimed |
| EP-1153093-A1 | CHEMICAL COMPOSITION FOR INK | Avecia Limited (GB) | 2001-11-14 | — | — | EP | claimed |
| US-6316571-B1 | USED AS CATALYST FOR THE PREPARATION OF ALKYLENE GLYCOLS BY REACTING AN ALKYLENE OXIDE WITH WATER | SHELL OIL COMPANY | 2001-11-13 | — | — | US | claimed |
| WO-2000037574-A1 | CHEMICAL COMPOSITION FOR INK | AVECIA LIMITED (GB) | 2000-06-29 | — | — | WO | claimed |
| EP-0727713-A1 | Photoresist having increased sensitivity and use thereof | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 1996-08-21 | — | — | EP | claimed |
| US-5300657-A | Process for preparing chelidonic acid | LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) | 1994-04-05 | — | — | US | claimed |
| EP-0308919-A1 | Compositions for topical use having melanin synthesis-inhibiting activity | Sansho Seiyaku Co., Ltd. (JP) | 1989-03-29 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12485112-B2 | Pharmaceutical composition | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, ADRA2C, CPT1A | KDM4E 4012/4885KMT2A 2630/4885DAO 3499/4885 |
| US-20260042084-A1 | SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP | SRMS, TYRO3, SELE | KDM4E 421/4885KMT2A 2367/4885DAO 229/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.